Successful resolution of Capgras syndrome with rivastigmine treatment in Lewy body dementia
Capgras syndrome, a delusional misidentification syndrome characterized by the belief that a close relative or friend has been replaced by an identical imposter, is a rare phenomenon often associated with psychotic disorders. Here, we present a case of a male in his early 80s with Lewy body dementia (LBD) who developed Capgras syndrome. Despite initial challenges in management, including thought blocking and word-finding difficulty, the patient experienced complete resolution of symptoms following treatment with rivastigmine, a cholinesterase inhibitor, commonly used in major neurocognitive disorders. This case highlights the potential efficacy of cholinesterase inhibitors in alleviating psychotic symptoms associated with Capgras syndrome, particularly in individuals with LBD.
Authors
- Jonathan Sasse
- Silpa Balachandran (ORCID: https://orcid.org/0000-0002-1504-7878)
- Rameez Sultan
- Rachida Bouhenni
Institutions
- Cleveland Clinic Akron General (US)
Publication Details
- Journal
- BMJ Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1136/bcr-2025-267800
- Primary Topic
- Face Recognition and Perception
- Type
- article
- Field-Weighted Citation Impact
- 0.00